Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-02 @ 1:28 AM
Study NCT ID:
NCT05929651
Status:
COMPLETED
Last Update Posted:
2025-09-22
First Post:
2023-06-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-09-09
Completion Date Type:
ACTUAL
First Submit Date:
2023-06-12
First Submit QC Date:
None
Study First Post Date:
2023-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-29
Results First Submit QC Date:
None
Results First Post Date:
2025-09-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-29
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED